Skip to content

Precise Mutation Detection in Low-Abundance Tumor-Derived Extracellular Vesicles via Microfluidic Immunomagnetic Reversible Affinity Capture.

Sep 2026 · Analytical Chemistry · Vol 98 36, pp. 27226-27234 · 0 citations · 20 references
Medicine

TL;DR

The MIRACLE platform is developed, an integrated system combining microfluidic magneto-controllable reversible affinity capture with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for efficient, multiplexed detection of tumor-derived EV DNA mutations.

Abstract

Molecular diagnostic technologies based on liquid biopsy are increasingly vital for clinical tumor molecular profiling. Compared to highly fragmented and easily degradable cell-free DNA (cfDNA), extracellular vesicles (EVs) offer distinct advantages by protecting nucleic acids from degradation. Enrichment of tumor-derived EVs using specific surface markers significantly enhances the relative abundance of mutant nucleic acids, establishing a foundation for highly sensitive mutation detection. To fully leverage this enrichment strategy, we developed the MIRACLE platform, an integrated system combining microfluidic magneto-controllable reversible affinity capture with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) for efficient, multiplexed detection of tumor-derived EV DNA mutations. The platform utilizes anti-EpCAM-functionalized magnetic beads to construct a reversible capture interface within a herringbone-structured microfluidic chip, achieving over 98% capture efficiency of tumor-derived EVs under turbulence-enhanced conditions. Following EV lysis, a 7-plex multiplex single base extension assay coupled with MALDI-TOF-MS analysis enables simultaneous and accurate identification of seven mutation sites with single-nucleotide resolution. Furthermore, the platform achieved a detection limit of 0.05% for tumor-derived EVs within a background of wild-type EVs. Validation using plasma samples from 26 colorectal cancer patients demonstrated 96.2% accuracy and 93.3% sensitivity, successfully detecting key mutations including G12V, G13D, and G12D. The tumor EV enrichment-guided mutation detection strategy established in this study provides a precise, multiplexed, and clinically applicable approach for molecular profiling in liquid biopsy.

View source

Similar papers

Aug 2026

Sensitive and Reproducible SERS Profiling of Tumor-Derived EVs via Uniform Microfluidic Nanobowl Arrays for Pancreatic Cancer Management.

A microfluidic SERS platform integrating plasmonic nanobowl arrays that simultaneously achieve a high enhancement factor and signal reproducibility and provides a promising tool for EV-based precision oncology.

Ruoke Wang, Ai-Peng Chen, Yu-Qing Wang et al. · 0 citations
Sep 2026

Cascade-Amplified Microfluidic Detection of Tumor Biomarkers via Metal-DNA Nanospheres Activating CRISPR-Cas12a Assay.

A highly efficient signal-transduction strategy utilizing Fe-coordinated DNA nanospheres (FDNSs)─a programmable, metal-nucleic acid assembly─as a high-capacity DNA reservoir for amplified biomarker sensing, providing a robust and portable solution for cancer screening in resource-limited settings.

Wen-Jian Zhao, Xiao-Wei Luan, Wen-Xiu Long et al. · 0 citations
Sep 2026

DNA Tetrahedral Nanoprobes-Based Logic-Gated FRET Sensor for in Situ Analysis of Dual MicroRNAs in Extracellular Vesicles.

Conventional analysis of extracellular vesicle (EV)-derived microRNAs relies on vesicle lysis and RNA extraction, which disrupt native vesicular structure and eliminate intravesicular molecular cargoes. Here, we report a rigid DNA tetrahedral nanoprobes-based logic-gated Förster resonance energy transfer (FRET) platfor...

Fang-Zhou Lan, Guang-Jin Tian, Ai-Peng Chen et al. · 0 citations
Aug 2026

Photoactivated liquid-liquid phase separation-based cascade CRISPR/Cas12a electrochemical platform for sensitive small extracellular vesicles detection.

An electrochemical platform based on the photoactivated liquid-liquid phase separation cascaded Cas12a amplification (PL-cCas12a) for ultrasensitive and specific detection of sEVs surface proteins and represents a promising tool for non-invasive early cancer diagnosis.

Yi-Ping Zhu, Shihua Luo, Min Luo et al. · 0 citations
Sep 2026

Co-profiling of exosomal proteins and microRNAs using single microbead confinement for breast cancer diagnosis.

A single microbead-confined dual-mode detection system that selectively captures TEXs for concurrent quantification of protein and miRNA biomarkers and is the first demonstration of a universal PNA modification strategy that harnesses a DNA mediator to prevent AuNPs self-aggregation.

Zhi-Heng Luo, Peng-Bo Zhang, Mou Li et al. · 0 citations
Review Open access Aug 2026

Advances in Extracellular Vesicle-Based Surface-Enhanced Raman Spectroscopy for Cancer Diagnosis

As a noninvasive liquid biopsy approach, extracellular vesicle (EV)-based detection offers significant advantages in reflecting real-time tumor dynamis and overcoming the limitations of conventional tissue biopsy. EVs, nanoscale vesicles secreted by cells, carry diverse biomolecules such as proteins and nucleic acids,...

Shu-Yuan Zhao, Wen Lei, Juan Li et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.